No profile data available.
Veru Inc. (VERU) is a healthcare company in the targeted healthcare equipment industry, based in Miami, United States, with about 210 full-time employees.
It reported revenue of $0 for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -$22.73 million. In Q1 2026 (the quarter ended December 31, 2025) revenue was $0. United States was its largest region in fiscal year 2024, with 32% of revenue. Its market capitalization was $38.84 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended September 30, 2025; market data as of December 4, 2025.
, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
Veru reported $0 in revenue for fiscal year 2025, down 100.0% from $16.89 million in fiscal year 2024. In Q1 2026 revenue was $0.
United States: 32% of revenue by region in fiscal year 2024, followed by Other (28%).
$38.84 million as of December 4, 2025.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Sensus Healthcare, Inc. (SRTS), Lancer Orthodontics, Inc. (LANZ), electroCore, Inc. (ECOR), Nephros, Inc. (NEPH).